People walk by a CVS Pharmacy store in the Manhattan borough of New York City.
Shannon Stapleton | Reuters
CVS Health‘s fourth-quarter earnings beat Wall Street’s expectations on Tuesday as its pharmacy sales got a lift and it expands Covid-19 testing and vaccines.
Shares of the company were up 1.4% in premarket trading.
Here’s what the company reported for the fiscal fourth quarter ended Dec. 31, compared with what analysts were expecting, based on a survey of analysts by Refinitiv:
- Earnings per share: $1.30 adjusted vs. $1.24 expected
- Revenue: $69.55 billion vs. $68.75 billion expected
The drugstore chain reported fiscal fourth-quarter net income of $975 million, or 75 cents per share, down…